Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ADCT.N
ADCT.N logo

ADCT.N Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy ADC Therapeutics SA (ADCT) Today? Analysis, Price Targets, and 2026 Outlook.

No data

No data

No data

No data

Growth

Profitability

Efficiency

Wall Street analysts forecast ADCT.N stock price to rise
3 Analyst Rating
Wall Street analysts forecast ADCT.N stock price to rise
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 3.780
sliders
Low
5
Averages
7.33
High
10
Current: 3.780
sliders
Low
5
Averages
7.33
High
10
H.C. Wainwright
Robert Burns
Buy
maintain
$7 -> $8
AI Analysis
2026-03-23
Reason
H.C. Wainwright
Robert Burns
Price Target
$7 -> $8
AI Analysis
2026-03-23
maintain
Buy
Reason
H.C. Wainwright analyst Robert Burns raised the firm's price target on ADC Therapeutics to $8 from $7 and keeps a Buy rating on the shares. The firm updated the company's model post the Q4 report.
H.C. Wainwright
Robert Burns
Buy
downgrade
$8 -> $7
2025-10-16
Reason
H.C. Wainwright
Robert Burns
Price Target
$8 -> $7
2025-10-16
downgrade
Buy
Reason
H.C. Wainwright analyst Robert Burns lowered the firm's price target on ADC Therapeutics to $7 from $8 and keeps a Buy rating on the shares. The firm reduced the price target after factoring in the private placement financing.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ADCT.N
Unlock Now

People Also Watch